Lung cancer screening (LCS) with low-dose CT (LDCT) is an effective tool for reducing lung cancer mortality among high-risk individuals, yet utilization of such screening remains low. What can be done to remedy this situation?

Whenever advanced imaging for low-back pain gets knocked as the “poster child” for overutilization in U.S. healthcare—not an uncommon occurrence—the context of the charge tends to waft away, unconsidered. That’s problematic. To be sure, lumbar-spine MRI in particular has a dicey cost-benefit proposition all its own. The scan’s technical component alone can ring up a bill north of $3,000.

Anne Klibanski, MD, has been named interim president and CEO of Partners HealthCare. Klibanski’s current leadership responsibilities within the Partners system include research, academia and clinical work. She will succeed CEO David Torchiana, MD, who recently announced his plans to retire at the end of April. 

Medical specialties across the board are getting creative as they work to bring millennials, aka “Generation Y,” into the fold. And even if there’s little truth behind the stereotypical associations—participation trophies, videogame addictions, fear of commitment—millennial radiologists are challenging the profession to adjust now or struggle to remain relevant later.

CMS has proposed covering a new form of cancer therapy, CAR T-cell therapy, under Medicare. The proposal would create a uniform standard of covering the treatment, which uses a patient’s own immune system to fight the disease.

When President Donald Trump signed a federal funding bill into law on Feb. 15, it included text that said that all mammography providers must include updated information about breast density in reports sent to both patients and their physicians.

The new American Society of Breast Surgeons' recommendations are based on a comprehensive review of the most impactful evidence in modern literature, data and national guidelines.

Genetic testing should be available for all breast cancer patients to determine hereditary risk in addition to standard imaging exams, according to new guidelines published Feb. 14 by The American Society of Breast Surgeons.